Literature DB >> 15731171

The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells.

Shen Gao1, Peng Lee, Hua Wang, William Gerald, Michael Adler, Liying Zhang, Yun-Fang Wang, Zhengxin Wang.   

Abstract

Androgens provide survival signals to prostate epithelial cells, and androgen ablation induces apoptosis in the prostate gland. However, the molecular mechanisms of actions of the androgen-signaling pathway in these processes are not fully understood. Here, we report that androgens induced expression of the cellular Fas/FasL-associated death domain protein-like inhibitory protein (c-FLIP) gene, which is a potent inhibitor of Fas/FasL-mediated apoptosis. The androgen receptor was recruited to the promoter of the c-FLIP gene in the presence of androgens. We found that c-FLIP promoter contained multiple functional androgen response elements. In addition, we show that c-FLIP overexpression accelerated progression to androgen independence by inhibiting apoptosis in LNCaP prostate tumors implanted in nude mice. Our results suggest that the androgen receptor affects survival and apoptosis of prostate cells through regulation of the c-FLIP gene in response to androgens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731171      PMCID: PMC1855294          DOI: 10.1210/me.2004-0445

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  48 in total

1.  HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.

Authors:  Y Wen; M C Hu; K Makino; B Spohn; G Bartholomeusz; D H Yan; M C Hung
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

2.  Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split.

Authors:  X Yu; P Li; R G Roeder; Z Wang
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis.

Authors:  Kai Ge; Mohamed Guermah; Chao-Xing Yuan; Mitsuhiro Ito; Annika E Wallberg; Bruce M Spiegelman; Robert G Roeder
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

4.  Two classes of androgen receptor elements mediate cooperativity through allosteric interactions.

Authors:  K J Reid; S C Hendy; J Saito; P Sorensen; C C Nelson
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

5.  Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.

Authors:  X Xie; X Zhao; Y Liu; C Y Young; D J Tindall; K M Slawin; D M Spencer
Journal:  Hum Gene Ther       Date:  2001-03-20       Impact factor: 5.695

6.  Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.

Authors:  A W Partin; W J Catalona; J A Finlay; C Darte; D J Tindall; C Y Young; G G Klee; D W Chan; H G Rittenhouse; R L Wolfert; D L Woodrum
Journal:  Urology       Date:  1999-11       Impact factor: 2.649

7.  Bcl-2 accelerates multistep prostate carcinogenesis in vivo.

Authors:  E M Bruckheimer; S Brisbay; D J Johnson; J R Gingrich; N Greenberg; T J McDonnell
Journal:  Oncogene       Date:  2000-11-02       Impact factor: 9.867

8.  Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.

Authors:  L C Amler; D B Agus; C LeDuc; M L Sapinoso; W D Fox; S Kern; D Lee; V Wang; M Leysens; B Higgins; J Martin; W Gerald; N Dracopoli; C Cordon-Cardo; H I Scher; G M Hampton
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

9.  Molecular analysis of the prostate-specific antigen upstream gene enhancer.

Authors:  G Farmer; E S Connolly; J Mocco; L P Freedman
Journal:  Prostate       Date:  2001-01-01       Impact factor: 4.104

10.  Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.

Authors:  N Craft; C Chhor; C Tran; A Belldegrun; J DeKernion; O N Witte; J Said; R E Reiter; C L Sawyers
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  26 in total

1.  Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth.

Authors:  Yaxiong Tang; Xuesen Li; Zhongbo Liu; Anne R Simoneau; Jun Xie; Xiaolin Zi
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

2.  A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression.

Authors:  Wei Qi; Hong Wu; Lin Yang; Douglas D Boyd; Zhengxin Wang
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

3.  Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy.

Authors:  Clare McCourt; Pamela Maxwell; Roberta Mazzucchelli; Rodolfo Montironi; Marina Scarpelli; Manuel Salto-Tellez; Joe M O'Sullivan; Daniel B Longley; David J J Waugh
Journal:  Clin Cancer Res       Date:  2012-05-23       Impact factor: 12.531

Review 4.  Opportunities and challenges in combination gene cancer therapy.

Authors:  Kent L Nastiuk; John J Krolewski
Journal:  Adv Drug Deliv Rev       Date:  2015-12-23       Impact factor: 15.470

5.  Decoy receptor 3 is a prognostic factor in renal cell cancer.

Authors:  Stephan Macher-Goeppinger; Sebastian Aulmann; Nina Wagener; Benjamin Funke; Katrin E Tagscherer; Axel Haferkamp; Markus Hohenfellner; Sunghee Kim; Frank Autschbach; Peter Schirmacher; Wilfried Roth
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

6.  Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA.

Authors:  Longgui Wang; Xuanyi Zou; Aaron D Berger; Christian Twiss; Yi Peng; Yirong Li; Jason Chiu; Hongfeng Guo; Jaya Satagopan; Andrew Wilton; William Gerald; Ross Basch; Zhengxin Wang; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

7.  beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.

Authors:  Udi Gluschnaider; Guy Hidas; Gady Cojocaru; Vladimir Yutkin; Yinon Ben-Neriah; Eli Pikarsky
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

8.  LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.

Authors:  Yirong Li; Longgui Wang; Miao Zhang; Jonathan Melamed; Xiaomei Liu; Robert Reiter; Jianjun Wei; Yi Peng; Xuanyi Zou; Angel Pellicer; Michael J Garabedian; Anna Ferrari; Peng Lee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model.

Authors:  Manonmani Ganapathy; Rita Ghosh; Xie Jianping; Xiaoping Zhang; Roble Bedolla; John Schoolfield; I-Tien Yeh; Dean A Troyer; Aria F Olumi; Addanki P Kumar
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

10.  Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms.

Authors:  Diping Wang; Ji Lu; Donald J Tindall
Journal:  Cancer Lett       Date:  2013-02-09       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.